Home » Newsletters » BioWorld

BioWorld

Feb. 4, 1994

View Archived Issues

MOLECULAR BIOSYSTEMS' ALBUNEX APPROVED IN SWEDEN

CENTOCOR REACQUIRES TOCOR II UNITS

ECOGEN LISTS WARRANTS

VERTEX UNDERWRITERS EXERCISE OVERALLOTMENT

ONCOR RAISES $24M FROM OFFERING

APPOINTMENTS AND ADVANCEMENTS

CANGUARD COMPLETES OFFERING

ZENECA SEEDS DEVELOPS GENE INSERTION TECHNOLOGY

ZENECA CREATES GENOME GROUP

CALGENE EXPECTS LARGE 1994 LOSS DUE TO SLOW FDA ACTION

CYGNUS, P&G TO DEVELOP SMOKING CESSATION PRODUCTS

BIOTECH START-UP LICENSES CELL DEATH GENES FROM M.I.T.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026